The roll-out is obviously extremely complex and this recent faux selling down probably was to get smart people positions prior to its inevitable unveiling. The selling has miraculously dried up and buying looks much stronger. This company has a strong path to revenue most other companies would die for.
Ann: Proteomics appoints medical devices sales agency for Europe, page-5
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.60M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 63.0¢ | 59.0¢ | $118.5K | 197.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28000 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 8340 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |